Delivery Order SPE2DB24D2010-SPE2DB25FAABU
Award Date
6/27/25
Potential Completion Date
6/30/25
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,128.81, is for the delivery of 100 capsules of the medication Vyvanse 60 mg. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of May 2, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 units of the medication Vyvanse 50 mg capsules. The contract has a firm fixed-price of $3,604.44 and a performance period through May 7, 2025. The contract is not set-aside and was competed openly. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,162.05, is for the supply of Vyvanse 60 mg capsules. It is a firm-fixed-price contract with an ultimate completion date of April 2, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 100 units of the medication Vyvanse 30 mg capsules, with a firm fixed price of $1,849.04 and a performance period ending on April 21, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,381.58 firm fixed-price contract is for the delivery of 4,567,168,394 units of the prescription medication Vyvanse 50 mg capsules. The contract has an ultimate completion date of February 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,368.57 contract is for the delivery of 4,564,529,038 units of the medication Vyvanse (40 mg capsules) with a performance period through May 8, 2024. The contract was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a $1,747.03 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Vyvanse 60 mg capsules. The contract has a firm fixed-price pricing type and a period of performance through September 30, 2024. There is no set-aside designation indicated. AmerisourceBergen, a major pharmaceutical distributor, is providing these prescription medications to support DLA's medical supply requirements. This contract is likely part of a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,301.30, is for the delivery of 100 units of the prescription medication Vyvanse 60 mg capsules. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp, a for-profit organization, has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,337.70 firm fixed-price contract is for the delivery of 100 units of the medication Vyvanse 30 mg capsules. The contract has a completion date of June 17, 2025 and is not set-aside. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,399.16, is for the delivery of 100 units of the prescription medication Vyvanse 50 mg capsules. The delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, valued at $999,999,999.00. This IDC serves as a...